| Literature DB >> 34095126 |
Wei Wang1, Brittany M Jack1, Henry H Wang1, Matthew A Kavanaugh1, Robin L Maser2, Pamela V Tran1.
Abstract
Primary cilia are small, antenna-like organelles that detect and transduce chemical and mechanical cues in the extracellular environment, regulating cell behavior and, in turn, tissue development and homeostasis. Primary cilia are assembled via intraflagellar transport (IFT), which traffics protein cargo bidirectionally along a microtubular axoneme. Ranging from 1 to 10 μm long, these organelles typically reach a characteristic length dependent on cell type, likely for optimum fulfillment of their specific roles. The importance of an optimal cilia length is underscored by the findings that perturbation of cilia length can be observed in a number of cilia-related diseases. Thus, elucidating mechanisms of cilia length regulation is important for understanding the pathobiology of ciliary diseases. Since cilia assembly/disassembly regulate cilia length, we review the roles of IFT in processes that affect cilia assembly/disassembly, including ciliary transport of structural and membrane proteins, ectocytosis, and tubulin posttranslational modification. Additionally, since the environment of a cell influences cilia length, we also review the various stimuli encountered by renal epithelia in healthy and diseased states that alter cilia length and IFT.Entities:
Keywords: IFT-A; IFT-B; cilia disassembly; ciliogenesis; ectocytosis; kidney; posttranslational modification
Year: 2021 PMID: 34095126 PMCID: PMC8170031 DOI: 10.3389/fcell.2021.661350
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
FIGURE 1The primary cilium and roles of IFT in cilium assembly/disassembly. Consisting of a 9 + 0 arrangement of a microtubular axoneme ensheathed by a specialized ciliary membrane, the primary cilium assembles initially within the cytoplasm at the modified centriole (1), which becomes the basal body that forms the base of the primary cilium at the plasma membrane. Extension and maintenance of the cilium, along with the entry and exit of structural and functional components and the BBSome, are mediated by IFT (2–4). Roles for IFT in ectocytosis (5) and cilia disassembly (6) have also been implicated (see text for details). The positive (+) and negative (–) ends of axonemal and cytoplasmic microtubules are indicated. The polycystins, PC1 and PC2, are localized at the ciliary membrane and are mutated in ADPKD.
Mammalian cilia lengths.
| Renal epithelia | Collecting ducts, 6 wks | ∼4 | ||
| Tubules distal to the proximal tubule, P7 | 3.5 ± 1.7 | |||
| Cholangiocyte | 5–12 months | 3.26 ± 1.29 | ||
| Neuron | Hypothalamic arcuate nucleus, 21–30 weeks | ∼3.5 | ||
| Hypothalamus | E12.5, E15.5 | ∼0.5 | ||
| E18.5 P1 | ∼1 | |||
| P7 | ∼1.5 | |||
| P14 | ∼2 | |||
| P28, P60 | ∼3.5 | |||
| Hippocampal dentate gyrus, P14 | ∼2.8 | |||
| Hippocampus, P15 | ∼3.2 | |||
| Cerebellum, 3–5 months | ∼3.8 (1–8) | |||
| Neural tube | E9.5 | ∼1 (0.5–2) | ||
| Osteocyte | 1 month | 2.3 (1.5–3.4) | ||
| MLO-Y4 cells | ∼2.8 | |||
| Osteoblast | 1 month | 2.9 (1.4–4.3) | ||
| Primary osteoblasts, P0 | ∼2.6 | |||
| MC3T3-E1 | 3 ± 0.8 (1–5) | |||
| Chondrocyte | E16.5 | 1.20 ± 0.01 | ||
| P1 | 1.19 ± 0.02 (1–1.7) | |||
| P3 | ∼1.6 (1–3) | |||
| P5 | ∼1.9 (1–3) | |||
| Primary chondrocytes, E16.5 | 2.82 ± 0.05 | |||
| Primary chondrocytes, P0, P7 | ∼3 | |||
| Endothelia | Primary endothelial cells, E15.5 | ∼0.85 | ||
Mammalian IFT-B ciliary phenotypes.
| No cilia length defects | MEF | Less GLI2 at ciliary tip, increased ciliary PTCH1 and SMO | ||
| No cilia length defects | MEF, primary dermal fibroblasts | Increased ciliary SMO; diminished GLI2 at ciliary distal tip; decreased BBS and Arl6 | ||
| Increased cilia length | Patient chondrocytes | None reported | ||
| Reduced ciliated cells and reduced number of cilia longer than 3 mm | Patient fibroblasts | No abnormalities in IFT or Hh protein ciliary localization but increased mRNA expression of | ||
| No cilia length defects | RPE | |||
| No cilia length defects but reduced numbers of microtubule doublets and disrupted circular arrangement of microtubules | Neural tube, RPE | Reduced GLI2 and GLI3 at ciliary tip; no KIF17 at ciliary tip | ||
| Loss of nodal cilia | Mouse node | |||
| Shortened cilia but wider range of cilia lengths | Patient fibroblasts | Reduced IFT88 | ||
| No cilia | Mesenchymal cells, renal epithelial cells, bone cells | |||
| No cilia | RPE | |||
| No cilia | MEF, node | |||
| No cilia length defects | Patient fibroblasts | Altered ciliary distribution pattern of Ift57 | ||
| No cilia | C3H10T1/2 mesenchymal cells | |||
| No cilia length defects | MEF, renal epithelial cells | None reported but decreased | ||
| No cilia/less ciliated cells; no abnormalities | RPE, NIH/3T3 | In mild | ||
| No cilia or severely shortened | Mouse node, embryonic neuroepithelium | |||
| No cilia | MEF, neural tube |
Mammalian IFT-A ciliary phenotypes.
| Extremely short cilia | Neural tube, MEF | No Arl13B, ACIII, or SMO entry; IFT-B accumulation | ||
| Slightly shortened cilia with bulbous distal tip | RPE | Loss of IFT-A around basal body, no entry of SMO or ARL13B; IFT-B, BBS4 accumulation | ||
| No obvious length defects | Neural tube, MEF | Decreased ACIII; slightly increased GLI2 at ciliary distal tip | ||
| Short with bulbous distal tip | Mouse node, MEF | Increased IFT-B, Gli2, Gli3 at distal tip; no TULP3 | ||
| No cilia | RPE | Loss of IFT-A and GPR161 around basal body, normal IFT-B around basal body; no SMO entry | ||
| Short with bulbous distal tip | Limb buds | |||
| Shortened cilia with bulbous distal tip | Patient fibroblasts; RPE | Increased BBS4 and BBS5, Gli2, IFT-B, IFT-A, Kif3A; no ARL13B, INNP5E, SSTR3, MCHR1, serotonin receptor; reduced SMO | ||
| Shortened cilia with bulbous distal tip | RPE | Increased IFT88, BBS4; no ARL13B | ||
| Shortened cilia | Patient fibroblasts | |||
| Shortened with bulbous distal tip | Limb bud, MEF, 3T3-LT1, renal epithelial | IFT-B, IFT-A, BBS, SMO accumulation at distal tip; decreased Arl13B, INNP5E, IFT-A | ||
| Normal cilia length with bulbous distal tip | RPE | IFT-B, IFT-A, SMO, GPR161 accumulation at distal tip | ||
| Normal | MEF | Normal | ||
| No length defects | RPE; renal epithelia | Decreased SSTR3 and MCHR1; severely reduced ARL13B, reduced polycystin 2 | ||
| Shortened | RPE | No ARL13B or INNP5E |
Modulators of renal cilia length.
| ↓ intracellular Ca2+ | ↑ | IMCD, MEK, BME | Increased anterograde IFT speed | |
| ↑ intracellular cAMP | ↑ | IMCD, MEK, BME | Activated PKA; increased anterograde IFT speed | |
| Fluid flow | ↓ | IMCD, MEK, BME | ↓ cAMP; decreased cAMP and cilia length response abolished by | |
| H2O2 (reactive oxygen species) | Deciliation | MDCK | ||
| Dopamine | ↑ | LLC-PK1 | Increased cilia length increases intracellular Ca2+ response to fluid shear stress | |
| Cobalt chloride (hypoxia) | ↑ | MDCK | Increased HIF1-alpha | |
| aldosterone | ↑ | mCCD | Reduced degradation of IFT88 | |
| ↑ | Collecting duct; cyst-lining renal epithelia | |||
| ↑ | Cyst lining renal epithelia | |||
| Ischemia | ↓ 1 day after; ↑ 8 days after | Bowman’s capsule parietal epithelium, proximal tubule, collecting duct | Deciliation | |
| ↑ | Cystic renal epithelia of developing kidney | Increased Akap12, a scaffolding protein that interacts with PKA, cyclins, and protein kinase C | ||
| Hypoxia (chronic renal injury) | ↑ | Fetal ovine renal epithelia | Increased cilia length increased intracellular Ca2+ response to fluid shear stress | |
| Mineralocorticoid receptor ko | ↓ | Distal nephron | Inability to respond to aldosterone |